However, TOX has been identified as a crucial factor in tumor-specific T-cell differentiation and CD8+ T-cell exhaustion, linking it to the prognosis of cancers or response prediction, or the enhancement of cancer immunotherapy [7–10]. This evidence concerns the gene CD8A and cancer.